It belongs to the same class of compounds as BPC-157, Sermorelin, and other therapeutic peptides, though it works through an entirely different receptor system
As the medical aesthetics and wellness industry continues to expand, compounded products, from peptides and hormones to injectables, have become commonplace in medspas and functional medicine practices

But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response

GHK has also been found to possess powerful cell protective actions, such as multiple anti-cancer activities and anti-inflammatory actions, lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts, suppression of molecules thought to accelerate the diseases of aging such as NFB, anti-anxiety, anti-pain and anti-aggression activities, DNA repair, and activation of cell cleansing via the proteasome system
Although its not fully understood, several factors appear to be at play: 1
It is written for the reader who genuinely wants to understand what ProHealth Longevity's BPC-157 capsules are, what the brand says about them, what the current research landscape looks like, and whether this product makes sense for their specific situation